Delivery Order SPE2DB22D3004-SPE2DB25FQE13
Award Date
4/7/25
Potential Completion Date
4/8/25
Potential Value
$9.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,132.83, is for the supply of Otezla 30 mg tablets. It is a firm fixed-price contract with a period of performance through March 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $15,739.44, is for the delivery of Otezla 30 mg tablets over a period ending on April 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Otezla 30 mg tablets. The contract has a ceiling value of $96,872.70 and a period of performance through August 27, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,401.24 firm fixed-price contract is for the supply of Otezla 30 mg tablets and has a completion date of September 20, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,208.14 firm fixed-price contract is for the supply of Otezla 30 mg tablets. The contract has an ultimate completion date of September 12, 2024 and is not a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through December 2025 for delivering a wide...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC). The $3,579.68 firm fixed-price contract is for the delivery of Otezla 30 mg tablets to support federal healthcare programs. The contract has a period of performance through November 5, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 IDC with the DLA Troop...
This is a federal contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,212.01, is for the delivery of Otezla 30 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of November 15, 2023. The contract is not designated as a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,939.04 firm-fixed-price contract is for the supply of Otezla 30 mg tablets to support federal healthcare programs. The contract has an ultimate completion date of December 13, 2023. AmerisourceBergen holds a broader $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $43,491.98, is for the supply of 4,567,958,181 units of the medication Otezla 30 mg Tablet 60s. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,340.95, is for the delivery of Otezla 30 mg tablets to support federal medical procurement needs, particularly for military and veteran healthcare systems. The contract is not set aside and is a firm fixed price delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite...